Skip Navigation

Your Environment. Your Health.

Person Details

Superfund Research Program

Margaret R. Karagas

Dartmouth College
Geisel School of Medicine at Dartmouth Department of Epidemiology
7927 Rubin Building
One Medical Center Drive
Lebanon, NH 03756-1000
Phone: 603-653-9010
Fax: 603-653-9093
Email: margaret.karagas@dartmouth.edu

Projects

Research Briefs

Hazardous Waste Sites

18 SF sites in State of New Hampshire

  • Dartmouth College: Epidemiology, Biomarkers and Exposure Assessment of Metals

Elizabeth Mine

  • Dartmouth College: Epidemiology, Biomarkers and Exposure Assessment of Metals

Sites in Concord, New Hampshire

  • Dartmouth College: Epidemiology, Biomarkers and Exposure Assessment of Metals

Sites in Lebanon, New Hampshire and Surrounding Communities

  • Dartmouth College: Epidemiology, Biomarkers and Exposure Assessment of Metals

Publications

2016

  • Everson TM, Armstrong DA, Jackson BP, Green BB, Karagas MR, Marsit CJ. 2016. Maternal cadmium, placental PCDHAC1, and fetal development. Reproductive Toxicology65:263-271. doi:10.1016/j.reprotox.2016.08.011 PMID:27544570
  • Farzan SF, Gossai A, Chen Y, Chasan-Taber L, Baker E, Karagas MR. 2016. Maternal arsenic exposure and gestational diabetes and glucose intolerance in the New Hampshire birth cohort study. Environmental Health15:doi:10.1186/s12940-016-0194-0 PMID:27315352 PMCID:PMC5090982
  • Goossens ME, Isa F, Brinkman MT, Mak D, Reulen RC, Wesselius A, Benhamou S, Bosetti C, Bueno-de-Mesquita HB, Carta A, Allam MF, Golka K, Grant EJ, Jiang X, Johnson KC, Karagas MR, Kellen E, La Vecchia C, Lu C, Marshall J, Moysich KB, Pohlabeln H, Porru S, Steineck G, Stern MC, Tang L, Taylor JA, van den Brandt P, Villeneuve PJ, Wakai K, Weiderpass E, White E, Wolk A, Zhang Z, Buntinx F, Zeegers MP. 2016. International pooled study on diet and bladder cancer: the bladder cancer, epidemiology and nutritional determinants (BLEND) study: design and baseline characteristics. Arch Public Health 74:30. doi:10.1186/s13690-016-0140-1 PMID:27386115 PMCID:PMC4933992
  • Punshon T, Li Z, Marsit CJ, Jackson BP, Baker E, Karagas MR. 2016. Placental Metal Concentrations in Relation to Maternal and Infant Toenails in a US Cohort. Environ Sci Technol50(3):1587–1594. doi:10.1021/acs.est.5b05316 PMID:26727403

2015

  • Andrew AS, Gui J, Hu T, Wyszynski A, Marsit CJ, Kelsey KT, Schned AR, Tanyos SA, Pendleton EM, Ekstrom RM, Li Z, Zens MS, Borsuk M, Moore JH, Karagas MR. 2015. Genetic polymorphisms modify bladder cancer recurrence and survival in a USA population-based prognostic study. BJU Int 115(2):238-247. doi:10.1111/bju.12641 PMID:24666523
  • Andrew AS, Marsit CJ, Schned AR, Seigne JD, Kelsey KT, Moore JH, Perreard L, Karagas MR, Sempere LF. 2015. Expression of tumor suppressive microRNA-34a is associated with a reduced risk of bladder cancer recurrence. Int J Cancer137(5):1157-1166. doi:10.1002/ijc.29413 PMID:25556547 PMCID:PMC4485975
  • Farzan S, Chen Y, Wu F, Jiang JY, Liu M, Baker E, Korrick SA, Karagas MR. 2015. Blood pressure changes in relation to arsenic exposure in a US pregnancy cohort. Environ Health Perspect 123:999-1006. doi:10.1289/ehp.1408472 PMID:25793356 PMCID:PMC4590746
  • Farzan S, Karagas MR, Jiang JY, Wu F, Liu M, Newman JD, Jasmine F, Kibriya MG, Paul-Brutus R, Parvez F, Argos M, Eunus M, Ahmed A, Rakibuz-Zaman M, Hasan R, Sarwar G, Slavkovich VN, Graziano JH, Ahsan H, Chen Y, Scannell Bryan M, Islam T. 2015. Gene-arsenic interaction in longitudinal changes of blood pressure: Findings from the Health Effects of Arsenic Longitudinal Study (HEALS) in Bangladesh. Toxicol Appl Pharmacol288:95-105. doi:10.1016/j.taap.2015.07.017 PMID:26220686 PMCID:PMC4606937
  • Grandjean P, Barouki R, Bellinger DC, Casteleyn L, Chadwick LH, Cordier S, Etzel R, Gray K, Ha E, Junien C, Karagas MR, Kawamoto T, Lawrence BP, Perera F, Prins GS, Rosenfeld CS, Sherr DH, Sly PD, Suk WA, Sun Q, Toppari J, van den Hazel P, Walker CL, Heindel JJ. 2015. Life-long implications of developmental exposure to environmental stressors: New perspectives. Endocrinology156(10):3408-3415. doi:10.1210/EN.2015-1350 PMID:26241067 PMCID:PMC4588822
  • Karagas MR, Gossai A, Pierce BL, Ahsan H. 2015. Drinking water arsenic contamination, skin lesions, and malignancies: A systematic review of the global evidence. Curr Environ Health Rep2(1):52-68. doi:10.1007/s40572-014-0040-x PMID:26231242 PMCID:PMC4522704
  • Pearce N, Blair AE, Vineis P, Ahrens W, Andersen A, Anto JM, Armstrong BK, Baccarelli A, Beland FA, Berrington A, Bertazzi PA, Birnbaum LS, Brownson RC, Bucher JR, Cantor KP, Cardis E, Cherrie JW, Christiani DC, Cocco P, Coggon D, Comba P, Demers PA, Dement JM, Douwes J, Eisen EA, Engel LS, Fenske RA, Fleming LE, Fletcher T, Fontham E, Forastiere F, Frentzel-Beyme R, Fritschi L, Gerin M, Goldberg M, Grandjean P, Grimsrud TK, Gustavsson P, Haines A, Hartge P, Hansen J, Hauptmann M, Heederik D, Hemminki K, Hemon D, Hertz-Picciotto I, Hoppin JA, Huff J, Jarvholm B, Kang D, Karagas MR, Kjaerheim K, Kjuus H, Kogevinas M, Kriebel D, Kristensen P, Kromhout H, Laden F, Lebailly P, LeMasters G, Lubin JH, Lynch CF, Lynge E, Mannetje A, McMichael AJ, McLaughlin J, Marrett L, Martuzzi M, Merchant JA, Merler E, Merletti F, Miller A, Mirer F, Monson RR, Nordby K, Olshan A, Parent M, Perera F, Perry MJ, Pesatori AC, Pirastu R, Porta M, Pukkala E, Rice C, Richardson DB, Ritter L, Ritz B, Ronckers CM, Rushton L, Rusiecki JA, Rusyn I, Samet JM, Sandler DP, de Sanjose S, Schernhammer E, Costantini A, Seixas N, Shy C, Siemiatycki J, Silverman DT, Simonato L, Smith AH, Smith MT, Spinelli JJ, Spitz MR, Stallones L, Stayner LT, Steenland K, Stenzel M, Stewart BW, Stewart P, Symanski E, Terracini B, Tolbert PE, Vainio H, Vena J, Vermeulen R, Victora CG, Ward EM, Weinberg CR, Weisenburger DD, Wesseling C, Weiderpass E, Zahm SH. 2015. IARC monographs: 40 years of evaluating carcinogenic hazards to humans. Environ Health Perspect 123:507-14. doi:10.1289/ehp.1409149 PMID:25712798 PMCID:PMC4455595
  • Punshon T, Chen S, Finney L, Howard L, Jackson BP, Karagas MR, Ornvold K. 2015. High-resolution elemental mapping of human placental chorionic villi using synchrotron X-ray fluorescence spectroscopy. Anal Bioanal Chem407(22):6839-6850. doi:10.1007/s00216-015-8861-5 PMID:26138895 PMCID:PMC4663034
  • Punshon T, Davis MA, Marsit CJ, Theiler SK, Baker E, Jackson BP, Conway DC, Karagas MR. 2015. Placental arsenic concentrations in relation to both maternal and infant biomarkers of exposure in a US cohort. Journal of Exposure Science and Environmental Epidemiology25:599-603. doi:10.1038/jes.2015.16 PMID:25805251 PMCID:PMC4583336

2014

2013

  • Chen Y, Karagas MR. 2013. Arsenic and Cardiovascular Disease: New Evidence from the United States. Ann Intern Med 159:713. PMCID:PMC4077583
  • Cottingham KL, Karimi R, Gruber JF, Zens MS, Sayarath V, Folt CL, Punshon T, Karagas MR, Morris JS. 2013. Diet and toenail arsenic concentrations in a New Hampshire population with arsenic-containing water. Nutr J 12:149. doi:10.1186/1475-2891-12-149 PMID:24237880 PMCID:PMC3907042
  • Fei DL, Koestler DC, Li Z, Giambelli C, Sanchez-Mejias A, Gosse JA, Marsit CJ, Karagas MR, Robbins DJ. 2013. Association between In Utero arsenic exposure, placental gene expression, and infant birth weight: A US birth cohort study. Environmental Health12:doi:10.1186/1476-069X-12-58 PMID:23866971 PMCID:PMC3733767
  • Gilbert-Diamond D, Li Z, Perry AE, Spencer SK, Gandolfi A, Karagas MR. 2013. A population-based case-control study of urinary arsenic species and squamous cell carcinoma in New Hampshire, USA. Environ Health Perspect 121(10):1154-1160. doi:10.1289/ehp.1206178 PMID:23872349 PMCID:PMC3801199
  • Hu T, Andrew AS, Karagas MR, Moore JH. 2013. Statistical epistasis networks reduce the computational complexity of searching three-locus genetic models. Pacific Symposium on Biocomputing 397-408. doi:10.1142/9789814447973_0039
  • Saunders JE, Jastrzembski BG, Buckey JC, Enriquez D, MacKenzie TA, Karagas MR. 2013. Hearing loss and heavy metal toxicity in a Nicaraguan mining community: Audiological results and case reports. Audiol Neurootol 18:101-113. doi:10.1159/000345470
  • Urbanowicz RJ, Andrew AS, Karagas MR, Moore JH. 2013. Role of genetic heterogeneity and epistasis in bladder cancer susceptibility and outcome: A learning classifier system approach. Journal of the American Medical Informatics Association 20:603-612. doi:10.1136/amiajnl-2012-001574 PMID:23444013 PMCID:PMC3721175
  • Wyszynski A, Tanyos SA, Rees JR, Marsit CJ, Kelsey KT, Schned AR, Pendleton EM, Zens MS, Karagas MR, Andrew AS. 2013. Body mass and smoking are modifiable risk factors for recurrent bladder cancer. Cancerdoi:10.1002/cncr.28394 PMID:24122218 PMCID:PMC3946933

2012

2011

2010

  • Christensen BC, Smith A, Zheng S, Koestler DC, Houseman E, Marsit CJ, Wiemels JL, Nelson HH, Karagas MR, Wrensch MR, Kelsey KT, Wiencke JK. 2010. DNA Methylation, Isocitrate Dehydrogenase Mutation, and Survival in Glioma. J Natl Cancer Inst103:143-153.
  • Fei DL, Li H, Kozul-Horvath CD, Black KE, Singh S, Gosse JA, DiRenzo J, Martin KA, Wang B, Hamilton JW, Karagas MR, Robbins DJ. 2010. Activation of hedgehog signaling by the environmental toxicant arsenic may contribute to the etiology of arsenic-induced tumors. Cancer Res70(5):1981-1988. doi:10.1158/0008-5472.can-09-2898
  • Greene CS, Himmelstein DS, Nelson HH, Kelsey KT, Williams SM, Andrew AS, Karagas MR, Moore JH. 2010. Enabling personal genomics with an explicit test of epistasis. Pacific Symposium on Biocomputing 327-36. doi:10.1142/9789814295291_0035
  • Gui J, Andrew AS, Andrews PC, Nelson HA, Kelsey KT, Karagas MR, Moore JH. 2010. A simple and computationally efficient sampling approach to covariate adjustment for multifactor dimensionality reduction analysis of epistasis. Hum Hered 70:219-225. doi:10.1159/000319175 PMID:20924193 PMCID:PMC2982850
  • Karagas MR. 2010. Arsenic-related mortality in Bangladesh. The Lancet376(9737):213-214. doi:10.1016/S0140-6736(10)61002-1 (Completed with ARRA Funds)
  • Koestler DC, Marsit CJ, Christensen BC, Karagas MR, Bueno R, Sugarbaker DJ, Kelsey KT, Houseman EA. 2010. Semi-supervised recursively partitioned mixture models for identifying cancer subtypes. Bioinformatics26(20):2578-2585. doi:10.1093/bioinformatics/btq470 (Completed with ARRA Funds)
  • Kwong RC, Karagas MR, Kelsey KT, Mason RA, Tanyos SA, Schned AR, Marsit CJ, Andrew AS. 2010. Arsenic exposure predicts bladder cancer survival in a US population. World J Urol28:487-92. doi:10.1007/s00345-009-0477-y PMID:19834714 PMCID:PMC3296964 (Completed with ARRA Funds)
  • Marsit CJ, Houseman EA, Christensen BC, Gagne LA, Wrensch MR, Nelson HH, Wiemels JL, Zheng S, Wiencke JK, Andrew AS, Schned AR, Karagas MR, Kelsey KT. 2010. Identification of Methylated Genes Associated with Aggressive Bladder Cancer. PLoS One5:e12334. doi:10.1371/journal.pone.0012334 PMID:20808801 PMCID:PMC2925945
  • Moore LE, Baris D, Figueroa JD, Garcia-Closas M, Schwenn M, Johnson A, Lubin JH, Hein DW, Dagnall CL, Colt JS, Kida M, Jones MA, Schned AR, Cherala S, Chanock SJ, Cantor KP, Silverman DT, Rothman N, Karagas MR. 2010. GSTM1 null and NAT2 slow acetylation genotypes, smoking intensity and bladder cancer risk: results from the New England bladder cancer study and NAT2 meta-analysis. Carcinogenesis32:182-9. doi:10.1093/carcin/bgq223 PMID:21037224 PMCID:PMC3026839
  • Rothman N, Garcia-Closas M, Chatterjee N, Malats N, Wu X, Figueroa JD, Real FX, Van Den Berg D, Matullo G, Baris D, Thun M, Kiemeney LA, Vineis P, De Vivo I, Albanes D, Purdue MP, Rafnar T, Hildebrandt MA, Kiltie AE, Cussenot O, Golka K, Kumar R, Taylor JA, Mayordomo JI, Jacobs KB, Kogevinas M, Hutchinson A, Wang Z, Fu Y, Prokunina-Olsson L, Burdett L, Yeager M, Wheeler W, Tardon A, Serra C, Carrato A, Garcia-Closas R, Lloreta J, Johnson A, Schwenn M, Karagas MR, Schned AR, Andriole G, Grubb R, Black A, Jacobs EJ, Diver WR, Gapstur SM, Weinstein SJ, Virtamo J, Cortessis VK, Gago-Dominguez M, Pike MC, Stern MC, Yuan J, Hunter DJ, McGrath M, Dinney CP, Czerniak B, Chen M, Yang H, Vermeulen SH, Aben KK, Witjes J, Makkinje RR, Sulem P, Besenbacher S, Stefansson K, Riboli E, Brennan P, Panico S, Navarro C, Allen NE, Bueno-de-Mesquita HB, Trichopoulos D, Caporaso N, Landi MT, Canzian F, Ljungberg B, Tjonneland A, Clavel-Chapelon F, Bishop DT, Teo MT, Knowles MA, Guarrera S, Polidoro S, Ricceri F, Sacerdote C, Allione A, Cancel-Tassin G, Selinski S, Hengstler JG, Dietrich H, Fletcher T, Rudnai P, Gurzau ES, Koppova K, Bolick SC, Godfrey A, Xu Z, Sanz-Velez JI, Garcia-Prats MD, Sanchez M, Valdivia G, Porru S, Benhamou S, Hoover RN, Fraumeni JF, Silverman DT, Chanock SJ. 2010. A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci. Nat Genet42(11):978-984. doi:10.1038/ng.687 PMID:20972438 PMCID:PMC3049891
  • Wilhelm CS, Kelsey KT, Butler RA, Plaza S, Gagne LA, Zens MS, Andrew AS, Morris S, Nelson HH, Schned AR, Karagas MR, Marsit CJ. 2010. Implications of LINE1 methylation for bladder cancer risk in women. Clinical Cancer Research16:1682-1689. doi:10.1158/1078-0432.ccr-09-2983
  • Wilhelm-Benartzi C, Koestler DC, Houseman E, Christensen BC, Wiencke JK, Schned AR, Karagas MR, Kelsey KT, Marsit CJ. 2010. DNA methylation profiles delineate etiologic heterogeneity and clinically important subgroups of bladder cancer. Carcinogenesis31(11):1972-1976. doi:10.1093/carcin/bgq178 PMID:20802236 PMCID:PMC2966555 (Completed with ARRA Funds)

2009

2008

  • Andrew AS, Jewell DA, Mason RA, Whitfield ML, Moore JH, Karagas MR. 2008. Drinking-water arsenic exposure modulates gene expression in human lymphocytes from a U.S. population. Environ Health Perspect 116(4):524-531. doi:10.1289/ehp.10861 PMID:18414638 PMCID:PMC2290973
  • Houseman EA, Christensen BC, Yeh R, Marsit CJ, Karagas MR, Wrensch MR, Nelson HH, Wiemels JL, Zheng S, Wiencke JK, Kelsey KT. 2008. Model-based clustering of DNA methylation array data: A recursive-partitioning algorithm for high-dimensional data arising as a mixture of beta distributions. BMC Biochem9:365. doi:10.1186/1471-2105-9-365 PMID:18782434 PMCID:PMC2553421
  • Moore JH, Karagas MR, Andrew AS. 2008. Analysis of Complex Datasets. Chapter 16 in: Molecular Epidemiology of Chronic Diseases. John Wiley & Sons Ltd, West Sussex, pp.207-222.
  • Moore JH, Karagas MR, Andrew AS. 2008. Novel analytical methods for association studies. Chapter 12 in: Molecular Epidemiology: Applications in Cancer and Other Human Diseases. nforma Health Care, pp.169-187.
  • Schned AR, Andrew AS, Marsit CJ, Kelsey KT, Zens MS, Karagas MR. 2008. Histological classification and stage of newly diagnosed bladder cancer in a population-based study from the Northeastern United States. Scand J Urol Nephrol42(3):237-42.

2007

2006

  • Andrew AS, Burgess JL, Meza MM, Demidenko E, Waugh MG, Hamilton JW, Karagas MR. 2006. Arsenic exposure is associated with decreased DNA repair in vitro and in individuals exposed to drinking water arsenic. Environ Health Perspect 114:1193-1198. doi:10.1289/ehp.9008 PMID:16882524 PMCID:PMC1552016
  • Andrew AS, Nelson HH, Kelsey KT, Moore JH, Meng AC, Casella DP, Tosteson TD, Schned AR, Karagas MR. 2006. Concordance of multiple analytical approaches demonstrates a complex relationship between DNA repair gene SNPs, smoking and bladder cancer susceptibility. Carcinogenesis27(5):1030-1037.
  • Ayotte JD, Baris D, Cantor KP, Colt JS, Robinson GR, Lubin JH, Karagas MR, Hoover RN, Fraumeni JF, Silverman DT. 2006. Bladder cancer mortality and private well use in New England: an ecological study. J Epidemiol Community Health60:168-172. doi:10.1136/jech.2005.038620 PMID:16415269 PMCID:PMC2566149
  • Ayotte JD, Nolan BT, Nuckols JR, Cantor KP, Robinson GR, Baris D, Hayes L, Karagas MR, Bress W, Silverman DT, Lubin JH. 2006. Modeling the probability of arsenic in groundwater in New England as a tool for exposure assessment. Environ Sci Technol40(11):3578-85. doi:10.1021/es051972f
  • Karagas MR, Weinstock MA, Nelson HH. 2006. Keratinocyte Carcinomas. Chapter 64 in: Cancer Epidemiology and Prevention. Oxford University Press, New York, NY.
  • Manuguerra M, Saletta F, Karagas MR, Berwick M, Veglia F, Vineis P, Matullo G. 2006. XRCC3 and XPD/ERCC2 single nucleotide polymorphisms and the risk of cancer: a HuGE review. Am J Epidemiol164(4):297-302.
  • Marsit CJ, Houseman EA, Eddy K, Bueno R, Sugarbaker DJ, Nelson HH, Karagas MR, Kelsey KT, Christensen BC. 2006. Examination of a CpG island methylator phenotype and implications of methylation profiles in solid tumors. Cancer Res66(21):10621-9.
  • Marsit CJ, Karagas MR, Danaee H, Liu M, Andrew AS, Schned AR, Nelson HH, Kelsey KT. 2006. Carcinogen exposure and gene promoter hypermethylation in bladder cancer. Carcinogenesis27(1):112-116.
  • Marsit CJ, Karagas MR, Schned AR, Kelsey KT. 2006. Carcinogen exposure and epigenetic silencing in bladder cancer. Ann N Y Acad Sci1076:810-21.
  • Sturup S, Folt CL, Karagas MR, Rees JR, Chen CY. 2006. Toenail mercury and dietary fish consumption. J Expo Anal Environ Epidemiol17:25-30. doi:10.1038/sj.jes.7500516

2005

  • Hirao S, Hirao T, Hirao Y, Marsit CJ, Schned AR, Devi-Ashok T, Nelson HH, Andrew AS, Karagas MR, Kelsey KT. 2005. Loss of heterozygosity on chromosome 9q and p53 alterations in human bladder cancer. Cancer104(9):1918-1923.
  • Karagas MR, Park S, Nelson HH, Andrew AS, Mott LA, Schned AR, Kelsey KT. 2005. Methylenetetrahydrofolate reductase (MTHFR) variants and bladder cancer: A population-based case-control study. Int J Hyg Environ Health208(5):321-327.
  • Karagas MR, Park S, Warren AJ, Hamilton JW, Nelson HH, Mott LA, Kelsey KT. 2005. Gender, smoking, glutathione-S-transferase variants and bladder cancer incidence: a population-based study. Cancer Lett219(1):63-69. doi:10.1016/j.canlet.2004.10.006
  • Kelsey KT, Hirao T, Hirao S, Devi-Ashok T, Nelson HH, Andrew AS, Colt JS, Baris D, Morris J, Schned AR, Karagas MR. 2005. TP53 alterations and patterns of carcinogen exposure in a U.S. population-based study of bladder cancer. Int J Cancer117(3):370-375.
  • Marsit CJ, Karagas MR, Andrew AS, Liu M, Danaee H, Schned AR, Nelson HH, Kelsey KT. 2005. Epigenetic Inactivation of SFRP Genes and TP53 Alteration Act Jointly as Markers of Invasive Bladder Cancer. Cancer Res65(16):7081-7085.

2004

  • Andrew AS, Schned AR, Heaney JA, Karagas MR. 2004. Bladder cancer risk and personal hair dye use. Int J Cancer109(4):581-586.
  • Carroll RJ, Ruppert D, Tosteson TD, Karagas MR. 2004. Nonlinear and nonparametric regression and instrumental variables. J Am Stat Assoc99(467):736-750.
  • Colt JS, Baris D, Stewart P, Schned AR, Heaney JA, Mott LA, Silverman DT, Karagas MR. 2004. Occupation and bladder cancer risk in a population-based case-control study in New Hampshire. Cancer Causes & Control15(8):759-769.
  • Karagas MR, Tosteson TD, Morris J, Demidenko E, Mott LA, Heaney JA, Schned AR. 2004. Incidence of transitional cell carcinoma of the bladder and arsenic exposure in New Hampshire. Cancer Causes & Control15(5):465-472.
  • Kelsey KT, Hirao T, Schned AR, Hirao S, Devi-Ashok T, Nelson HH, Andrew AS, Karagas MR. 2004. A population-based study of immunohistochemical detection of p53 alteration in bladder cancer. Br J Cancer90(8):1572-1576.
  • Kelsey KT, Park S, Nelson HH, Karagas MR. 2004. A Population-Based Case-Control Study of the XRCC1 Arg399Gln Polymorphism and Susceptibility to Bladder Cancer. Cancer Epidemiology Biomarkers & Prevention13(8):1337-1341.
  • Wickre JB, Folt CL, Sturup S, Karagas MR. 2004. Environmental exposure and fingernail analysis of arsenic and mercury in children and adults in a Nicaraguan gold mining community. Arch Environ Health59(8):400-409.

2003

  • Andrew AS, Karagas MR, Hamilton JW. 2003. Decreased DNA repair gene expression among individuals exposed to arsenic in United States drinking water. Int J Cancer104(3):263-268.
  • Andrew AS, Karagas MR, Klei L, Hamilton JW. 2003. Drinking water arsenic exposure is associated with decreased DNA repair gene expression. Toxicological Sciences72(S1):184.
  • Tosteson TD, Buzas JS, Demidenko E, Karagas MR. 2003. Power and sample size calculations for generalized regression models with covariate measurement error. Stat Med22(7):1069-1082.

2002

  • Andrew AS, Karagas MR, Schned AR, Hamilton JW. 2002. Decreased expression of DNA repair genes ERCC1, XPF, and XPB, but not XPG or XPA among individuals exposed to arsenic in drinking water. In: Proceedings of the 93rd Annual Meeting of the American Association for Cancer Research, April 6-10, 2002. San Francisco, CA.
  • Andrew AS, Mott LA, Heaney JA, Schned AR, Karagas MR. 2002. Bladder cancer risk and personal hair dye use in women. In: Proceedings of the 93rd Annual Meeting of the American Association for Cancer Research, April 6-10, 2002. San Francisco, CA.
  • Colt JS, Baris D, Clark SF, Ayotte JD, Ward MH, Nuckols JR, Cantor KP, Silverman DT, Karagas MR. 2002. Sampling private wells at past homes to estimate arsenic exposure: a methodologic study in New England. J Expo Anal Environ Epidemiol12(5):329-334.
  • Danaee H, Nelson HH, Karagas MR, Schned AR, Devi-Ashok T, Hirao T, Perry AE, Kelsey KT. 2002. Microsatellite instability at tetranucleotide repeats in skin and bladder cancer. Oncogene21(32):4894-4899.
  • Danaee H, Nelson HH, Karagas MR, Schned AR, Devi-Ashok T, Hirao T, Perry AE, Kelsey KT. 2002. Microsatellite instability at tetranucleotide repeats in skin and bladder cancer. In: Proceedings of the 93rd Annual Meeting of the American Association for Cancer Research, April 6-10, 2002. San Francisco, CA.
  • Karagas MR, Nelson HA, Kelsey KT, Morris S, Blum JD, Tosteson TD, Carey M, Le X. 2002. Urinary Arsenic species in relation to drinking water and toenail arsenic concentrations and genetic polymorphisms in GSTM1 in New Hampshire. Chapter 17 in: Biomarkers of Environmentally Associated Disease: Technologies, Concepts, and Perspectives. CRC Press Company, Boca Raton, FL.
  • Karagas MR, Nelson HA, Kelsey KT, Morris S, Blum JD, Tosteson TD, Carey M, Le X. 2002. Urinary arsenic species in relation to drinking water and toenail arsenic concentrations and genetic polymorphisms in GSTM1 in New Hampshire. Proceedings in Nucleic Research 17:251-261.
  • Karagas MR, Stukel TA, Tosteson TD. 2002. Assessment of cancer risk and environmental levels of arsenic in New Hampshire. Int J Hyg Environ Health205(1-2):85-94.
  • Schned AR, Karagas MR, Kelsey KT. 2002. Prevalence of bladder tumour types in a non-selected patient Population, classified according tothe World Health Organization/International Society of Urologic Pathologists(WHO/ISUP) System. Histopathology 41(S1):52-53.

2001

  • Karagas MR, Le X, Morris S, Blum JD, Lu X, Spate VL, Carey M, Stannard V, Klaue B, Tosteson TD. 2001. Markers of low level arsenic exposure for evaluating human cancer risks in a U.S. population. Int J Occup Med Environ Health 14(2):171-175. PMID:11548067
  • Karagas MR, Stukel TA, Morris J, Tosteson TD, Spencer SK, Greenberg ER. 2001. Skin cancer risk in relation to toenail arsenic concentrations in a US population-based case-control study. Am J Epidemiol153(6):559-565.
  • Park S, Karagas MR, Nelson HH, Mott LA, Bronson KM, Kelsey KT. 2001. X-ray repair cross-complementing gene 1 (XRCC1) polymorphisms and the risk of bladder cancer. In: Proceedings of the American Association for Cancer Research Annual Meeting, 2001.

2000

  • Karagas MR, Tosteson TD, Blum JD, Klaue B, Weiss JE, Stannard V, Spate VL, Morris J. 2000. Measurement of low levels of arsenic exposure: a comparison of water and toenail concentrations. Am J Epidemiol152(1):84-90.
  • Tosteson TD, Karagas MR. 2000. Designing an arsenic and bladder cancer case-control study. What sample size is needed to detect the beginning of dose-response?. Metal Ions in Biology and Medicine 6:28-30.

1999

  • Peters SC, Blum JD, Klaue B, Karagas MR. 1999. Arsenic occurrence in New Hampshire drinking water. Environ Sci Technol33(9):1328-1333.

1998

  • Karagas MR, Tosteson TD, Blum JD, Morris J, Baron JA, Klaue B. 1998. Design of an epidemiological study of drinking water arsenic exposure and cancer risk in a US population. Environ Health Perspect 106Suppl.4:1047-1050.
  • Nichols TA, Morris J, Mason MM, Spate VL, Baskett CK, Cheng TP, Tharp CJ, Scott JA, Horsman TL, Tawson AE, Karagas MR, Stannard V, Colbert JW. 1998. The study of human nails as an intake monitor for arsenic using neutron activation analysis. Journal of Radioanalytical and Nuclear Chemistry236(1-2):51-56. doi:10.1007/BF02386317

1996

Share This Page:

Page Options:

Request Translation Services